{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:48:19Z","timestamp":1777639699972,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.resinv.2024.02.015","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T04:54:27Z","timestamp":1709700867000},"page":"377-383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of the outcomes of Pneumocystis jirovecii pneumonia in rheumatoid arthritis patients treated with and without biologics"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8651-4149","authenticated-orcid":false,"given":"Shin-ichiro","family":"Ohmura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Shichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Masui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsutoshi","family":"Ichijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Homma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2024.02.015_bib1","first-page":"1874e6","article-title":"Pneumocystis pneumonia under anti-tumor necrosis factor therapy (PAT) study group. Pneumocystis pneumonia associated with infliximab in Japan","volume":"357","author":"Harigai","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2024.02.015_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/art.24283","article-title":"Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients","volume":"61","author":"Komano","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2024.02.015_bib3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3109\/s10165-012-0615-z","article-title":"Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors","volume":"22","author":"Tanaka","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.resinv.2024.02.015_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/s10165-005-0395-9","article-title":"Clinical characteristics of pneumocystis carinii pneumonia in patients with connective tissue diseases","volume":"15","author":"Sato","year":"2005","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.resinv.2024.02.015_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijid.2016.03.018","article-title":"Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients","volume":"46","author":"Traore","year":"2016","journal-title":"Int J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.resinv.2024.02.015_bib6","first-page":"19","article-title":"Pneumocystis pneumonia in human immunodeficiency virus-infected adults and adolescents: current concepts and future directions","volume":"9","author":"Tasaka","year":"2015","journal-title":"Clin Med Insights Circulatory, Respir Pulm Med"},{"key":"10.1016\/j.resinv.2024.02.015_bib7","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00296-009-0857-z","article-title":"Prognostic indicators related to death in patients with Pneumocystis pneumonia associated with collagen vascular diseases","volume":"29","author":"Aoki","year":"2009","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.resinv.2024.02.015_bib8","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/mr\/roac088","article-title":"Outcomes and risk factors for mortality in pneumocystis pneumonia patients with rheumatoid arthritis: a multicenter retrospective cohort study","volume":"33","author":"Mori","year":"2023","journal-title":"Mod Rheumatol."},{"key":"10.1016\/j.resinv.2024.02.015_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214324","article-title":"Prognostic factors of Pneumocystis pneumonia in patients with systemic autoimmune diseases","volume":"14","author":"Kageyama","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2024.02.015_bib10","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1007\/s10067-018-4157-4","article-title":"Differences in clinical Pneumocystis pneumonia in rheumatoid arthritis and other connective tissue diseases suggesting a rheumatoid-specific interstitial lung injury spectrum","volume":"37","author":"Shimada","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.resinv.2024.02.015_bib11","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1007\/s10067-021-05660-4","article-title":"Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study","volume":"40","author":"Hsu","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.resinv.2024.02.015_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3710652","article-title":"Comparison of the clinical characteristics of pneumocystis pneumonia between patients with rheumatoid arthritis being treated with biologics and those being treated without","author":"Akiyama","year":"2017","journal-title":"Biologics. Biomed Res Int."},{"issue":"1","key":"10.1016\/j.resinv.2024.02.015_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy","volume":"71","author":"Yale","year":"1996","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"10.1016\/j.resinv.2024.02.015_bib14","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/M20-1594","article-title":"Risk for serious infection with low-dose glucocorticoids in patients with rheumatoid arthritis : a cohort study","volume":"173","author":"George","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.resinv.2024.02.015_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2024.02.015_bib16","first-page":"2569","article-title":"Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum 2010"},{"key":"10.1016\/j.resinv.2024.02.015_bib17","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2169\/internalmedicine.8205-21","article-title":"Factors associated with pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving methotrexate: a single-center retrospective study","volume":"61","author":"Ohmura","year":"2022","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2024.02.015_bib18","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1186\/s12879-021-06895-x","article-title":"Low cut-off value of serum (1,3)-beta-D-glucan for the diagnosis of Pneumocystis pneumonia in non-HIV patients: a retrospective cohort study","volume":"21","author":"Taniguchi","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.resinv.2024.02.015_bib19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.chest.2023.08.009","article-title":"Low- versus conventional-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia in non-human immunodeficiency virus-infected patients: a multi-center, retrospective observational cohort study","volume":"165","author":"Nagai","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.02.015_bib20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jiac.2018.11.014","article-title":"Effectiveness and safety of lower dose sulfamethoxazole\/trimethoprim therapy for Pneumocystis jirovecii pneumonia in patients with systemic rheumatic diseases: a retrospective multicenter study","volume":"25","author":"Ohmura","year":"2019","journal-title":"J Infect Chemother"},{"issue":"25","key":"10.1016\/j.resinv.2024.02.015_bib21","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"8","key":"10.1016\/j.resinv.2024.02.015_bib22","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.3390\/ijms24087399","article-title":"Prognostic factors affecting death in patients with rheumatoid arthritis complicated by pneumocystis jirovecii pneumonia and one-year clinical course: the ANSWER cohort study","volume":"24","author":"Shiba","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"23","key":"10.1016\/j.resinv.2024.02.015_bib23","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/jama.2020.7819","article-title":"Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial","volume":"323","author":"Thomas","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.resinv.2024.02.015_bib24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/s10165-011-0523-7","article-title":"Prognosis of pneumocystis pneumonia complicated in patients with rheumatoid arthritis (RA) and non-RA rheumatic diseases","volume":"22","author":"Yoshida","year":"2012","journal-title":"Mod Rheumatol"},{"issue":"12","key":"10.1016\/j.resinv.2024.02.015_bib25","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jiac.2023.07.012","article-title":"A single-center, person-month-based analysis of the risk of developing Pneumocystis pneumonia (PCP) in immunosuppressed non-HIV patients: preventive effects of trimethoprim-sulfamethoxazole","volume":"29","author":"Miyake","year":"2023","journal-title":"J Infect Chemother"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534524000406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534524000406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:33:46Z","timestamp":1761950026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534524000406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2212534524000406"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2024.02.015","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the outcomes of Pneumocystis jirovecii pneumonia in rheumatoid arthritis patients treated with and without biologics","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2024.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of The Japanese Respiratory Society.","name":"copyright","label":"Copyright"}]}}